Evaluation of Transnasal Endoscopy During COVID-19 Pandemic

Study Overview
=================
Brief Summary
-----------------
Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is not influenced by the study. Following the examination, patient data is collected pseudonymously and a questionnaire is submitted to the patient.

Detailed Description
-----------------
COVID-19 is transmitted, among other things, by a droplet infection. Conventional gastroscopy through the patient's mouth is therefore considered a high-risk examination for the medical and nursing staff. Alternatively, gastroscopy can also be performed through the patient's nose. An advantage here is that the aerosol formation is naturally significantly reduced and the patient usually does not need sedation, since in transnasal endoscopy no stranglehold occurs. Transnasal endoscopy therefore appears to us, especially during the COVID-19 pandemic, as a safe alternative to conventional gastroscopy. Patients who received the indication for endoscopic diagnostics using gastroscopy in transnasal technique will be included into the study. The examination is carried out in standard technique and is not influenced by the study. Following the examination, patient data is collected pseudonymously and a questionnaire is sumbitted to the patient. Only patients who have the indication for gastroscopy in transnasal technique are included. A specific risk to patients cannot be foreseen.This study does not interfere with diagnostics or therapy.

Official Title
-----------------
Evaluation of Transnasal Endoscopy During COVID-19 Pandemic

Conditions
-----------------
Endoscopy

Intervention / Treatment
-----------------
* Other: gastroscopy in transnasal techique


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Indication for transnasal endoscopy Exclusion Criteria: pregnancy breast feeding contraindication to transnasal endoscopy pronounced blood clotting disorders

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 75 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Intervention Model: Single Group Assignment
Interventional Model Description: all patients with indication für gastroscopy in transnasal techique are included.
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Other: Gastroscopy in transnasal technique<br>All patients with indication for gastroscopy in transnasal techqiue are included. | Other: gastroscopy in transnasal techique<br>* All patients with indication for gastroscopy in transnasal technique are included.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Questionnaire | a questionnaire with 5 questions regarding the quality of the examination, technique and safety is presented to the patients | after examination, about 15 minutes | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
transnasal, gastroscopy, nursing